Young researcher Millicent Dockerill becomes a BRIDGE programme fellow

The Research and Grants Office (RGO) and the Vice-Rector for Research warmly congratulate:

  • Millicent Dockerill, Department of Organic Chemistry, Faculty of science, and co-founder of Reverso Therapeutics.

Further information: Reverso Therapeutics


7 Oct 2025

What's new?